Author

Tehila Gershon

Hebrew University of Jerusalem

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

Amandeep SinghiD· 1 shared Arun Kumar SharmaiD· 1 shared Deborah Duran· 1 shared Froma Oberman· 1 shared Gilad Wolf VaineriD· 1 shared Joel K. YisraeliiD· 1 shared Myriam GrunewaldiD· 1 shared Nadav WallisiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Amandeep SinghORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

AVJ16 inhibits the RNA binding protein IGF2BP1 in lung adenocarcinomas and prevents tumor growth in mice

Nadav Wallis, Tehila Gershon, Sojod Shaaby, Froma Oberman, Myriam Grunewald, Deborah Duran, Amandeep Singh, Gilad Wolf Vainer, Vladimir S. Spiegelman, Arun Kumar Sharma, Joel K. Yisraeli

AVJ16 inhibits IGF2BP1 in lung adenocarcinoma cells and xenografts, reducing proliferation, enhancing apoptosis, and preventing tumor growth.

Oncogene · Jul 8, 2025Peer-reviewedCancer Biology